Policy-makers move to curb drug abuse, diversion and disruptions to ensure quality supply.
- Published in:
- Formulary, 2011, v. 46, n. 6, p. 242
- By:
- Publication type:
- Article
Works matching IS 1082801X AND DT 2011 AND VI 46 AND IP 6
Results: 14
1
2
Drug Watch. Psychiatric conditions.
- Published in:
- Formulary, 2011, v. 46, n. 6, p. 244
- Publication type:
- Article
3
Specialty drug approvals trend upward; biobetters gain momentum.
- Published in:
- Formulary, 2011, v. 46, n. 6, p. 241
- By:
- Publication type:
- Article
4
Cancer, diabetes, cardiovascular agents fill pipeline.
- Published in:
- Formulary, 2011, v. 46, n. 6, p. 241
- By:
- Publication type:
- Article
5
Multiple sclerosis: A paradigm change with oral agents?
- Published in:
- Formulary, 2011, v. 46, n. 6, p. 228
- By:
- Publication type:
- Article
6
FDA: benefits of olmesartan continue to outweigh potential risks of cardiovascular mortality.
- Published in:
- Formulary, 2011, v. 46, n. 6, p. 227
- Publication type:
- Article
7
Topiramate reclassified as Category D due to potential link to oral clefts in newborns.
- Published in:
- Formulary, 2011, v. 46, n. 6, p. 227
- Publication type:
- Article
8
Telaprevir: A novel, protease inhibitor for the treatment of hepatitis C virus.
- Published in:
- Formulary, 2011, v. 46, n. 6, p. 205
- By:
- Publication type:
- Article
9
Expect CER to play a more notable role in payer policies, programs.
- Published in:
- Formulary, 2011, v. 46, n. 6, p. 203
- By:
- Publication type:
- Article
10
Ranibizumab and bevacizumab show equivalent effects on visual acuity in patients with neovascular AMD.
- Published in:
- Formulary, 2011, v. 46, n. 6, p. 203
- Publication type:
- Article
11
FDA Drug Approvals. FDA actions in brief.
- Published in:
- Formulary, 2011, v. 46, n. 6, p. 202
- Publication type:
- Article
12
FDA Drug Approvals. New molecular entity: Horizant.
- Published in:
- Formulary, 2011, v. 46, n. 6, p. 201
- Publication type:
- Article
13
FDA Drug Approvals. New biologic: Benlysta.
- Published in:
- Formulary, 2011, v. 46, n. 6, p. 201
- Publication type:
- Article
14
FDA Drug Approvals. Pipeline preview.
- Published in:
- Formulary, 2011, v. 46, n. 6, p. 201
- Publication type:
- Article